Metabolism News and Research

Latest Metabolism News and Research

SH2B1 protein plays a key role in controlling body weight, response to insulin and leptin

A single protein in brain cells may act as a linchpin in the body's weight-regulating system, playing a key role in the flurry of signals that govern fat storage, sugar use, energy balance and weight, University of Michigan Medical School researchers report.

29 Jan 2007

Nanoparticles from crab shells show promise for drug delivery

Nanoparticles made of chitosan, a naturally occuring polymer isolated from crab and shrimp shells, have shown promise as carriers of anticancer drugs, antitumor genes, and other novel therapeutic agents.

22 Jan 2007

Piolitazone shows promise for preventing brain injury from radiation therapy

Researchers at Wake Forest University School of Medicine are the first to report that in animal studies, a common diabetes drug prevents the memory and learning problems that cancer patients often experience after whole-brain radiation treatments.

10 Jan 2007

Specific gene found that protects some people with diabetes from severe kidney failure

A research team at Wake Forest University Baptist Medical Center and the University of Heidelberg has proven that a gene protects some people with diabetes from developing severe kidney failure or "end-stage renal disease."

9 Jan 2007

A central thermogenic-like mechanism in feeding regulation

During periods of fasting, brain cells responsible for stimulating the appetite make sure that you stay hungry.

2 Jan 2007

Major Alzheimer’s test for highest resolution clinical PET camera in the world

The University of Manchester's Wolfson Molecular Imaging Centre will carry out its first positron emission tomography (PET) brain scan on a patient volunteer this Friday (24 November 2006) at 10.00.

From The University of Manchester 23 Nov 2006

HRT shows promise in helping visual memory of postmenopausal women

Many women experience declines in their memory during and after menopause, a change thought to be due, in part, to the rapid hormonal changes they weather during that time.

20 Nov 2006

Lots of sweet food and drink increases risk of pancreatic cancer

Pancreatic cancer is a very serious form of cancer that is possibly caused when the pancreas produces heightened levels of insulin as a consequence of upset glucose metabolism. A well-known way of increasing insulin production is to eat a lot of sugar.

8 Nov 2006

Which works best in fighting the risk factors for diabetes - exercise or diet?

It's a toss up, according to a new study by a Saint Louis University researcher who is a member of a Washington University team of scientists examining whether a calorie-restrictive diet can extend people's lifespan.

8 Nov 2006

Long-term use of topiramate and kidney-stones

Topiramate (Topamax), a drug commonly prescribed to treat seizures and migraine headaches, can increase the propensity of calcium phosphate kidney stones, researchers at UT Southwestern Medical Center have found.

31 Oct 2006

Lab-on-a-chip nanoscale array monitors cellular processes

Researchers at Tel-Aviv University in Israel have developed a lab-on-a-chip device that can incorporate enzymes and even living cells in a nanoscale array capable of monitoring electrochemical reactions.

30 Oct 2006

Researchers uncover new way in which the aging process is linked to DNA damage

Researchers have uncovered a new way in which the aging process is linked to DNA damage--which occurs normally as a result of cell metabolism and environmental influences--and the various ways in which cells repair that damage.

23 Oct 2006

Scientists discover how brain turns on system designed to protect nerve cells from toxic "free radicals"

Scientists at Dana-Farber Cancer Institute report they have found how the brain turns on a system designed to protect its nerve cells from toxic "free radicals," a waste product of cell metabolism that has been implicated in some degenerative brain diseases, heart attacks, strokes, cancer, and aging.

20 Oct 2006

PGC-1 alpha implicated in Huntington's disease neurodegeneration

A metabolic disorder underlies the brain effects found in those with Huntington's disease, researchers report in an advance article publishing online October 19, 2006. The article will appear in the November 2006 issue of the journal Cell Metabolism, published by Cell Press.

20 Oct 2006

An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling

Using a combination of enzyme activity and metabolite profiling, we determined that this protein-whose function was previously unknown-serves as a key regulator of a lipid signaling network that contributes to cancer," said Benjamin F. Cravatt, a Scripps Research professor and a member of its Skaggs Institute for Chemical Biology who led the study.

20 Oct 2006

Incidence of kidney damage associated with coronary artery bypass surgery has increased significantly

The incidence of kidney damage associated with coronary artery bypass surgery has increased significantly over the past 16 years in the United States, but the rate of death from such damage has decreased significantly during the period, according to a new analysis.

16 Oct 2006

Food like an addictive drug for some people

Researchers in the U.S. have found that the same brain circuits are involved when obese people fill their stomachs as when drug addicts think about drugs and the discovery they say suggests an association between overeating and addiction.

3 Oct 2006

Research implicates brain circuits involved in drug craving and emotional response to food

Researchers at the U.S. Department of Energy's Brookhaven National Laboratory have found new clues to how the brain and the stomach interact with emotions to cause overeating and obesity.

2 Oct 2006

New understanding of how cells defend themselves

Biologists at the EPFL (Ecole Polytechnique Federale de Lausanne) have unveiled a new twist in a metabolic pathway that cells use to defend themselves against toxins made by disease-causing bacteria.

21 Sep 2006

Insulin receptor stops progression of Alzheimer's disease

Stimulation of a receptor in the brain that controls insulin responses has been shown to halt or diminish the neurodegeneration of Alzheimer's disease, providing evidence that the disease can be treated in its early stages, according to a study by researchers at Rhode Island Hospital and Brown Medical School.

21 Sep 2006

Metabolism News and Research

Latest Metabolism News and Research

SH2B1 protein plays a key role in controlling body weight, response to insulin and leptin

Nanoparticles from crab shells show promise for drug delivery

Piolitazone shows promise for preventing brain injury from radiation therapy

Specific gene found that protects some people with diabetes from severe kidney failure

A central thermogenic-like mechanism in feeding regulation

Major Alzheimer’s test for highest resolution clinical PET camera in the world

HRT shows promise in helping visual memory of postmenopausal women

Lots of sweet food and drink increases risk of pancreatic cancer

Which works best in fighting the risk factors for diabetes - exercise or diet?

Long-term use of topiramate and kidney-stones

Lab-on-a-chip nanoscale array monitors cellular processes

Researchers uncover new way in which the aging process is linked to DNA damage

Scientists discover how brain turns on system designed to protect nerve cells from toxic "free radicals"

PGC-1 alpha implicated in Huntington's disease neurodegeneration

An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling

Incidence of kidney damage associated with coronary artery bypass surgery has increased significantly

Food like an addictive drug for some people

Research implicates brain circuits involved in drug craving and emotional response to food

New understanding of how cells defend themselves

Insulin receptor stops progression of Alzheimer's disease

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog